A low-carbohydrate diet induces hepatic insulin resistance and metabolic associated fatty liver disease in mice
Objectives: Metabolic-associated fatty liver disease (MAFLD) is the most common chronic liver disease that can range from hepatic steatosis to non-alcoholic steatohepatitis (NASH), which can lead to fibrosis and cirrhosis. Recently, ketogenic diet (KD), a low carbohydrate diet, gained popularity as...
Main Authors: | Fen Long, Memoona R. Bhatti, Alexandra Kellenberger, Wenfei Sun, Salvatore Modica, Marcus Höring, Gerhard Liebisch, Jean-Philippe Krieger, Christian Wolfrum, Tenagne D. Challa |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | Molecular Metabolism |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212877823000091 |
Similar Items
-
From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications
by: Andrea Boccatonda, et al.
Published: (2023-03-01) -
Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy
by: Francesca Fianchi, et al.
Published: (2021-06-01) -
Endoplasmic Reticulum and Mitochondria Contacts Correlate with the Presence and Severity of NASH in Humans
by: Chaonan Jin, et al.
Published: (2022-07-01) -
Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time?
by: Nicolas Lanthier, et al.
Published: (2022-08-01) -
TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD
by: Andrea Caddeo, et al.
Published: (2021-12-01)